Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,549Revenue (TTM) $M160Net Margin (%)-70.0Altman Z-Score-1.3
Enterprise Value $M1,474EPS (TTM) $-0.7Operating Margin %-61.2Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.6Pre-tax Margin (%)-70.0Higher ROA y-yN
Price/Book55.710-y EBITDA Growth Rate %--Quick Ratio3.5Cash flow > EarningsY
Price/Sales8.85-y EBITDA Growth Rate %--Current Ratio3.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-52.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M171ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with ARRY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ARRY is held by these investors:



ARRY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LEFKOFF KYLEDirector 2017-03-31Sell45,000$8.921.68view
BAUM CHARLES MDirector 2017-03-28Sell25,000$9.27-2.16view
Redmile Group, LLC10% Owner 2016-09-28Sell2,492,578$6.3642.61view
Redmile Group, LLC10% Owner 2016-09-15Sell400,000$3.5159.14view
Redmile Group, LLC10% Owner 2016-09-15Buy400,000$3.51158.4view
Redmile Group, LLC10% Owner 2016-01-20Buy300,000$3.19184.33view
Redmile Group, LLC10% Owner 2016-01-12Buy75,000$3.6151.94view
Redmile Group, LLC10% Owner 2016-01-11Buy925,000$3.67147.14view
Redmile Group, LLC10% Owner 2015-10-01Buy782,592$4.5898.03view
Redmile Group, LLC10% Owner 2015-10-01Buy600,140$4.5898.03view

Quarterly/Annual Reports about ARRY:

News about ARRY:

Articles On GuruFocus.com
Array Biopharma To Present At The Goldman Sachs 38th Annual Global Healthcare Conference Jun 01 2017 
Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercializati May 31 2017 
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration May 30 2017 
Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2017 May 10 2017 
Array BioPharma Announces Positive Top-Line Results from Part 2 of the Phase 3 COLUMBUS Study of Bin May 09 2017 
Array BioPharma Announces Strategic Collaboration with Merck May 08 2017 
Array Biopharma To Report Financial Results For The Third Quarter Of Fiscal 2017 On May 10, 2017 May 03 2017 
Shalini Sharp Joins Array BioPharma Board of Directors Apr 27 2017 
Screen: Stocks With Estimated Revenue Up 5% - January Jan 18 2016 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 

More From Other Websites
Are Options Traders Betting on a Big Move in Array BioPharma (ARRY) Stock? Jun 23 2017
Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : June 21,... Jun 21 2017
ETFs with exposure to Array BioPharma, Inc. : June 16, 2017 Jun 16 2017
Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q3, 2017 By the Numbers : June 14, 2017 Jun 14 2017
Why Array BioPharma Inc. Sank 13.5% in May Jun 05 2017
Array Biopharma To Present At The Goldman Sachs 38th Annual Global Healthcare Conference Jun 01 2017
Blog Coverage: Array BioPharma and Bristol-Myers Squibb Partner to Investigate Combinations of... Jun 01 2017
Bristol-Myers Partners Array to Investigate Cancer Candidate May 31 2017
Biotech Movers: Akari, Array, Amicus May 31 2017
Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And... May 31 2017
Bristol-Myers Hookup Boosts Array BioPharma May 30 2017
Array BioPharma, Bristol-Myers Squibb to collaborate on cancer drug research May 30 2017
Biotech Movers: Array Shares Rise on Bristol-Myers Collaboration May 30 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration May 30 2017
How Two Biotechs Fell On Cancer Partnerships With Bristol-Myers May 30 2017
Blog Coverage: Mirna Announced Reverse Merger Agreement May 17 2017
Edited Transcript of ARRY earnings conference call or presentation 10-May-17 1:00pm GMT May 16 2017
Today's Research Reports on Stocks to Watch: Array Biopharma and Verastem May 11 2017
Array Biopharma Sees Positive Study Results From COLUMBUS Phase 2, But Commercialization May Prove... May 10 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}